or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

Representative Frank J. Pallone, Jr.'s Public Statements on Drugs

Full Name: Frank J. Pallone, Jr.
Office: U.S. House (NJ) - District 6, Democratic
First Elected: 11/08/1988
Last Elected: 11/06/2012
Next Election: 2014
Gender: Male
Family: Wife: Sarah; 3 Children: Rose Marie, Frank Andrew, Celeste Teresa
Birth Date: 10/30/1951
Birth Place: Long Branch, NJ
Home City: Long Branch, NJ
Religion: Roman Catholic
Date Title Location
April 16, 2013 Pallone Announces Report Finding Unregulated and Unsafe Oversight of Compounding Pharmacies Washington, DC
Oct. 9, 2012 Letter to Chairman Upton, Chairman Pitts, and Chairman Stearns Unknown
June 20, 2012 Statement by Congressman Pallone on the House Passage of the Food and Drug Administration Safety and Innovation Act Washington, DC
April 3, 2012 Pallone, Guthrie Call for Fairness in Generic Drug Approval Process Washington, DC
March 21, 2012 The Affordable Care Act: Keeping Seniors Healthy and Reducing Health Care Costs Washington, DC
Feb. 23, 2012 Letter to Margaret Hamburg, the Commissioner of the Food and Drug Administration Washington, DC
Feb. 17, 2012 Letter to The Honorable Margaret A. Hamburg, Commissioner U.S. Food and Drug Administration Unknown
Feb. 15, 2012 Medicare Washington, DC
Feb. 9, 2012 Members Introduce Bipartisan Legislation to Improve FDA Generic Drug Approvals Washington, DC
Feb. 9, 2012 Congressman Frank Pallone Introduces Legislation to Bring Low Cost Generic Drugs to Market Faster Washington, DC
Feb. 9, 2012 Bipartisan Group of Members Introduce Legislation to Improve Access to Lower Cost Generic Drugs Unknown
Sept. 9, 2011 Letter to The Honorable Jon Leibowitz Chairman Federal Trade Commission Unknown
June 15, 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 Washington, DC
June 14, 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 Washington, DC
April 12, 2011 Dingell, Waxman, Pallone, & DeGette Introduce Drug Safety Enhancement Act Washington, DC
March 24, 2011 Letter to Mr. Gregory J. Divis President Ther-Rx Corporation Chief Executive Officer KV Pharmaceutical Company Unknown
March 4, 2011 Letter to The Honorable Joseph R. Pitts Chairman Subcommittee on Health Unknown
March 2, 2011 Pallone Acts to Combat Prescription Drug Abuse Washington, DC
Jan. 24, 2011 Make It In America Washington, DC
Jan. 18, 2011 Honoring Sargent Shriver and Health Care Washington, DC
Dec. 17, 2010 Dingell, Waxman, Pallone, & Stupak Introduce Drug Safety Legislation Washington, DC
Sept. 24, 2010 Pallone Requests Thorough Review of FDA's Approval of Genetically Engineered Salmon Washington, DC
Sept. 20, 2010 Waxman, Dingell, Pallone & Stupak Open Discussion on Potentially Historic Changes in Drug Safety Laws Unknown
July 13, 2010 Bi-Partisan Group of Lawmakers Team Up to Combat Prescription Drug Abuse Washington, DC
June 10, 2010 Pallone Announces First Round of $250 Rebate Checks Now Being Sent to Tens of Thousands of Seniors Washington, DC
June 25, 2009 Hearing Of The Health Subcommittee Of The House Committee On Energy And Commerce - Comprehensive Health Reform Discussion Draft, Day Three Washington, DC
June 23, 2009 Panel II Of A Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Comprehensive Health Reform Washington, DC
June 18, 2009 Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - FDA Regulation Of Medical Devices Washington, DC
June 11, 2009 Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Emerging Health Care Issues: Follow-On Biologic Drug Competition Washington, DC
May 1, 2009 Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - The 2009 H1N1 Flu Outbreak And The United States Federal Response Washington, DC
Jan. 28, 2009 Key Energy and Commerce Members Introduce FDA Globalization Act Washington, DC
Sept. 23, 2008 Ryan Haight Online Pharmacy Consumer Protection Act of 2008 Washington, DC
July 31, 2008 Senate, House Members Introduce Bill to Provide Doctors With Unbiased Information About Prescription Drugs Washington, DC
July 30, 2008 Animal Drug User Fee Amendments of 2008 Washington, DC
July 24, 2008 Relating to the House Procedures Contained in Section 803 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Washington, DC
July 9, 2008 Pallone Statement at Health Markup of Animal Drug User Fee Bills & Michelle's Law Washington, DC
June 5, 2008 Pallone Statement at Health Hearing on Animal Drug User Fee Acts Washington, DC
May 1, 2008 Panel I of a Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Drug Safety Provisions of the Food and Drug Administration Globalization Act Discussion Draft Legislation Washington, DC
May 1, 2008 Panel II of a Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Drug Safety Provisions of the Food and Drug Administration Globalization Act Discussion Draft Legislation Washington, DC
Sept. 28, 2007 Pallone Introduces Bill to Correct the New Medicaid Reimbursement Rule for Pharmacists Washington, DC
Sept. 27, 2007 Pallone Commends President Bush for signing FDA Revitalization Act of 2007 into Law Washington, DC
Sept. 26, 2007 Hearing of the House Subcommittee on Health of the House Committee on Energy and Commerce - H.R. 3610, The Food and Drug Import Saftey Act Washington, DC
Sept. 19, 2007 Food and Drug Administration Amendments Act of 2007 Washington, DC
Aug. 21, 2007 Congressman Frank Pallone Joins RX4NJ to Promote Prescription Drug Access Programs to the Hispanic Community Washington, DC
July 11, 2007 Food And Drug Administration AMendments Act Of 2007 Washington, DC
June 19, 2007 Pallone Statement At Health Subcommittee Markup Of PDUFA, MDUFMA, Drug Safety & Pediastric Legislation Washington, DC
June 12, 2007 Pallone Statement At Health Hearin On PDUFA, MDUFMA, Drug Safety & Pediatric Legislation Washington, DC
May 22, 2007 Pallone Statement At Health Hearing On Programs Affecting Safety & Innovation In Pediatric Therapies Washington, DC
May 9, 2007 Pallone Statement At Health Hearing Assessing The Safety Of Our Nation's Drug Supply Washington, DC
May 2, 2007 Pallone Statement At Health Hearing: Assessing The Impact Of A Safe And Equitable Biosimilar Policy In The U.S. Washington, DC
Back to top